title: [Clinical practice guidelines for systemic lupus erythematosus: Recommendations for general clinical management].
abstract: Systemic lupus erythematosus (SLE) is a complex rheumatic multisystemic disease of autoimmune origin with significant potential morbidity and mortality. It is one of the most common autoimmune diseases with an estimated prevalence of 20-150 cases per 100,000 inhabitants. The clinical spectrum of SLE is wide and variable both in clinical manifestations and severity. This prompted the Spanish Ministry of Health, Social Services and Equality to promote and fund the development of a clinical practice guideline (CPG) for the clinical care of SLE patients within the Programme of CPG in the National Health System which coordinates GuiaSalud. This CPG is is intended as the reference tool in the Spanish National Health System in order to support the comprehensive clinical management of people with SLE by all health professionals involved, regardless of specialty and level of care, helping to standardize and improve the quality of clinical decisions in our context in order to improve the health outcomes of the people affected. The purpose of this document is to present and discuss the rationale of the recommendations on the general management of SLE, specifically, clinical follow-up, general therapeutic approach, healthy lifestyles, photoprotection, and training programmes for patients. These recommendations are based on the best available scientific evidence, on discussion and the consensus of expert groups.
authors.affiliation: Fundación Canaria de Investigación Sanitaria (FUNCANIS), La laguna, Santa Cruz de Tenerife, España; Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC), Madrid, España.
authors.forename: María M
authors.initials: MM
authors.lastname: Trujillo-Martín
authors.affiliation: Servicio de Reumatología, Hospital Universitario de Gran Canarias Dr. Negrín, Las Palmas de Gran Canaria, España. Electronic address: matrumar4@gmail.com.
authors.forename: Iñigo
authors.initials: I
authors.lastname: Rúa-Figueroa Fernández de Larrinoa
authors.affiliation: Unidad de Investigación de Enfermedades Autoinmunes, Servicio de Medicina Interna, Hospital Universitario Cruces, Barakaldo, Vizcaya, España.
authors.forename: Guillermo
authors.initials: G
authors.lastname: Ruíz-Irastorza
authors.affiliation: Servicio de Reumatología, Hospital Meixoeiro, Vigo, España; IRIDIS (Investigation in Rheumatology and Immuno-Mediated Diseases) Group, Instituto de Investigación Biomédica (IBI) de Vigo, Pontevedra y Ourense, España.
authors.forename: José María
authors.initials: JM
authors.lastname: Pego-Reigosa
authors.affiliation: Servicio de Medicina Interna, Hospital Virgen de Las Nieves, Granada, España.
authors.forename: José Mario
authors.initials: JM
authors.lastname: Sabio Sánchez
authors.affiliation: Red de Investigación en Servicios de Salud en Enfermedades Crónicas (REDISSEC), Madrid, España; Servicio de Evaluación y Planificación (SESCS), Servicio Canario de la Salud, Santa Cruz de Tenerife, España.
authors.forename: Pedro
authors.initials: P
authors.lastname: Serrano-Aguilar
mesh_terms: D000359:Aftercare / Q000379:methods; D003131:Combined Modality Therapy; D018450:Disease Progression; D006293:Health Promotion; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008180:Lupus Erythematosus, Systemic / Q000628:therapy*; D009313:National Health Programs; D013030:Spain
chemical_list: D007166:Immunosuppressive Agents
keywords: Clinical practice guidelines; Consenso; Consensus; Guía de práctica clínica; Lupus eritematoso sistémico; Systemic lupus erythematosus